StockData
Korsana Biosciences, Inc. logo

Korsana Biosciences, Inc. (KRSA) stock

KRSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30498% above fair value
$32.50−0.18 (-0.55%)

Close on Nov 17, 2026Market cap $152.14MP/E –Yield –

Korsana Biosciences operating margin

Operating margin is operating income as a percentage of revenue.

Korsana Biosciences's operating margin for the twelve months ending Jun 30, 2026 was -359.2%. For fiscal 2025 it was -239.8%, against -181.4% the year before. The highest annual figure on record is -181.4% in fiscal 2024.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-239.8%−58.4
FY2024Dec 31, 2024-181.4%+6061.0
FY2022Dec 31, 2022-6242.4%−4842.2
FY2021Dec 31, 2021-1400.2%+2139.2
FY2020Dec 31, 2020-3539.4%−765.1
FY2019Dec 31, 2019-2774.3%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2025Dec 31, 2025-81.8%−109.6
Q3 FY2025Sep 30, 2025-115.0%+466.5
Q2 FY2025Jun 30, 2025-1797.8%+2592.0
Q1 FY2025Mar 31, 2025-1798.8%+27.4
Q4 FY2024Dec 31, 202427.8%+2717.9
Q3 FY2024Sep 30, 2024-581.4%+2661.4
Q2 FY2022Jun 30, 2022-4389.9%−3850.7
Q1 FY2022Mar 31, 2022-1826.2%+19778.7
Q4 FY2021Dec 31, 2021-2690.1%+11764.1
Q3 FY2021Sep 30, 2021-3242.8%+2202.2
Q2 FY2021Jun 30, 2021-539.2%+2087.2
Q1 FY2021Mar 31, 2021-21604.8%−19574.4
Q4 FY2020Dec 31, 2020-14454.1%−12659.0
Q3 FY2020Sep 30, 2020-5445.0%−3441.0
Q2 FY2020Jun 30, 2020-2626.4%−596.1
Q1 FY2020Mar 31, 2020-2030.5%–
Q4 FY2019Dec 31, 2019-1795.1%–
Q3 FY2019Sep 30, 2019-2004.0%–
Q2 FY2019Jun 30, 2019-2030.3%–

More Korsana Biosciences figures

See a number that looks wrong?